MARIA GONZALEZ PELAEZ: Open Payments
NPI 1871374470 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 78 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $879 · 2025 $2,235
Food & beverage: $2,122Education: $114
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $287 |
| GlaxoSmithKline, LLC. | 18 | $275 |
| Verona Pharma, Inc. | 11 | $194 |
| GENZYME CORPORATION | 5 | $189 |
| Mallinckrodt Hospital Products Inc. | 5 | $169 |
| Stryker Corporation | 1 | $160 |
| Insmed, Inc. | 7 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $133 |
| ABBVIE INC. | 1 | $111 |
| ABIOMED | 1 | $104 |
Products named: DUPIXENT, Ohtuvayre, NUCALA, ACTHAR, BREZTRI, FLOWTRIEVER, Arikayce, EMBLAVEO.
Industry payments across FL — which companies pay providers there.
